Antimicrobial susceptibility of Stenotrophomonas maltophilia from United States medical centers (2019-2023).

Sader HS, Castanheira M, Arends SJR, Doyle TB

Open source

DOI
10.1128/aac.00124-25
Published
2025 Apr 2
Container
Antimicrobial agents and chemotherapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/aac.00124-25,
  title = {Antimicrobial susceptibility of Stenotrophomonas maltophilia from United States medical centers (2019-2023).},
  author = {Sader HS and Castanheira M and Arends SJR and Doyle TB},
  year = {2025},
  journal = {Antimicrobial agents and chemotherapy},
  doi = {10.1128/aac.00124-25},
  url = {https://doi.org/10.1128/aac.00124-25}
}

RIS

TY  - JOUR
TI  - Antimicrobial susceptibility of Stenotrophomonas maltophilia from United States medical centers (2019-2023).
AU  - Sader HS
AU  - Castanheira M
AU  - Arends SJR
AU  - Doyle TB
PY  - 2025
JO  - Antimicrobial agents and chemotherapy
DO  - 10.1128/aac.00124-25
UR  - https://doi.org/10.1128/aac.00124-25
ER  - 

APA

HS, S., M, C., SJR, A., & TB, D. (2025). Antimicrobial susceptibility of Stenotrophomonas maltophilia from United States medical centers (2019-2023).. Antimicrobial agents and chemotherapy. https://doi.org/10.1128/aac.00124-25

Source records